Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case Reports.

Hsu, Ping-Chih; Chen, Tai-Di; Tsai, Tsung-Yu; Yang, Cheng-Ta

Hsu, Ping-Chih; Chen, Tai-Di; Tsai, Tsung-Yu; Yang, Cheng-Ta.

Afiliación

Hsu PC; Department of Thoracic Medicine, Chang Gung Memorial Hospital at Linkou, Taoyuan City 33305, Taiwan.
Chen TD; Department of Medicine, College of Medicine, Chang Gung University, Taoyuan City 33302, Taiwan.
Tsai TY; Department of Medicine, College of Medicine, Chang Gung University, Taoyuan City 33302, Taiwan.
Yang CT; Department of Pathology, Chang Gung Memorial Hospital at Linkou, Taoyuan City 33305, Taiwan.

Clin Pract ; 13(1): 200-205, 2023 Jan 30.

Article en En | MEDLINE | ID: mdl-36826160

Palabras clave

ant-PD-1; bevacizumab; immunotherapy; nivolumab; non-small cell lung cancer; proteinuria; thrombotic microangiopathy (TMA)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Pract Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google